RESEARCH AND DEVELOPMENT SCENARIO IN INDIAN PHARMACEUTICAL COMPANIES SUBMITED BY: MR. SHAMSHAD AH DEPARTMENT OF PHARMACEUTICAL MANAGEMENT DEPARTMENT OF PHARMACEUTICAL MANAGEMENT NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH SEC. NO. 67‚ S.A.S. NAGAR MOHLI PUNJAB CONTENTS: * OBJECTIVES....................................................................................3 * INTRODUCTION.............................................................................3
Premium Pharmaceutical industry Clinical trial Drug discovery
Running head: PERSONAL STATEMENT TO PURSUE AN MBA Personal Statement to Pursue an MBA My personal statement begins with my American journey. A journey of faith and courage in the face of adversity that has taken me to where I am today. And it remains still a work in progress. And an MBA will surely help accelerate that. I was sixteen years old when my family left the Philippines‚ my birthplace and migrated to the United States to pursue the American dream that many in the
Premium Marketing Sales American Dream
References: 1. Adair‚ J. (1973) Action-Centred Leadership. New York‚:McGraw-Hill. 2. AstraZeneca (1999) Leadership in AstaZeneca. AstraZeneca HR‚ Dec 1999. 3. Bass‚ B. (1985) Leadership and Performance Beyond Expectations. New York: Free Press. 4. Bergmann‚ H.‚ Hurson‚ K. and Russ-Eft‚ D. (1999) everyone a Leader: A grassroots model for the new workplace. New
Premium Leadership Management Fiedler contingency model
Objective The objective of this portfolio is to analyze whether Pfizer Inc. is a market leader of producing ethical products in the pharmaceutical industry in Hong Kong. To achieve this objective‚ Pfizer needs to enlarge and rectify their marketing communications‚ (such as‚ adjust their promotional tools‚ differentiate their products...etc). Introduction Pfizer Inc. is established since 1849 by Charles Pfizer and Charles Earhart and up till now‚ it has 150 countries using their pharmaceutical
Premium
Investing helps your assets work for you. What is investing? Investing refers to the act of using your money to buy some sort of financial product or any other item‚ in the hope and expectation that the product will grow in value after you buy it. What are some type of investments? Almost anything you buy now that you think you can sell for more money later is considered an investment‚ including things like real estate‚ collectibles‚ stocks and bonds. So why invest? By investing your money‚ you
Premium Health care Investment
Individual Research Proposal Introduction In this day and age‚ we cannot deny that technology is a key aspect of our daily lives and has definitely made our lives more efficient and convenient in several aspects. 61 million individuals are using mobile phones for health related topics‚ 29 million patients exchange emails with physicians‚ and 9 million consumers use health communities online (Nicole Lucarelli). However‚ many pharmacies are currently not exploiting technology to benefit their companies
Premium Facebook Pharmaceutical industry Social media
BUSINESS DECISION MAKING INTRODUCTION Johnson and Johnson is an American multinational company founded in Brunswick ‚New Jersey in 1886 by American entrepreneur Robert Wood Johnson. It manufactures pharmaceuticals‚ medical devices and consumer products. J&J and its subsidiaries have operations in over 60 countries and sell their products in over 175 countries. Today‚ it employs 120‚000 people worldwide. They are the world’s second largest manufacturer of health care products and
Premium Johnson & Johnson Pharmaceutical industry SWOT analysis
TABLE OF CONTENTS I. INTRODUCTION 1 II. COMPANY HISTORY 1 III. CHIEF EXECUTIVE OFFICER 2 IV. MAJOR PRODUCTS 3 V. MAJOR COMPETITORS 5 VI. SALES HISTORY 6 VII. MAJOR FACTORS AFFECTING INVESTMENT POTENTIAL 7 VIII. STOCK PRICE DATA AND INVESTMENT ANALYSIS 8 IX. CONCLUSIONS & RECOMMENDATIONS 10 EXECUTIVE SUMMARY This company profile provides a preliminary investigation and analysis of Novartis International AG‚ a multinational pharmaceutical company based in Basel‚
Premium Pharmaceutical industry Novartis
Company profile Date of Establishment | 1935 | Revenue | 1386.83 ( USD in Millions ) | Market Cap | 249989.56450195 ( Rs. in Millions ) | Corporate Address | Mumbai Central‚‚Mumbai-400008‚ Maharashtra www.cipla.com | Management Details | Chairperson - Y K Hamied MD - Y K Hamied Directors - Amar Lulla‚ H R Manchanda‚ K A Hamied‚ M K Hamied‚ M R Raghavan‚ Mital Sanghvi‚ Pankaj Patel‚ Ramesh Shroff‚ S A A Pinto‚ S Radhakrishnan‚ V C Kotwal‚ Y K Hamied | Business Operation | Pharmaceuticals &
Premium Executive director Board of directors Managing director
Report on Communication at Mirror Image Commissioned by Tama Wilson‚ CEO of Mirror Image ? ? By Business Consultant Executive summary: Mirror Image needs an overhaul in communication between management and workers. After collecting information collected through the CEO and a resent staff survey‚ it is apparent that certain things are restricting good communication. With the help of great pre-existing research this report identifies several major issues. Distrust of management has led to
Premium Communication